Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01440023 · ClinicalTrials.gov registry record · Phase 1
Developing Cognitive Training for Tourette Syndrome
A Phase 1 study of Tourette Syndrome and Chronic Tic Disorders, sponsored by University of Wisconsin, Milwaukee.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT01440023 is a Phase 1 study of Tourette Syndrome and Chronic Tic Disorders that has completed, run by University of Wisconsin, Milwaukee. The registered enrollment target is 20 participants, below the 86-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01440023, a Phase 1 study of Tourette Syndrome and Chronic Tic Disorders, has completed, sponsored by University of Wisconsin, Milwaukee.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Many researchers suspect that individuals with Tourette Syndrome (TS) may have a poor cognitive ability (i.e., response inhibition; RI) that is essential to inhibit inappropriate response such as vocal or motor tics. The investigators aim to test whether a well-established behavior therapy for TS can be improved by increasing the individual's RI capabilities. To this end, 20 children will be randomly assigned to behavior therapy with computer-based RI training or behavior therapy with placebo computer-based cognitive training. The investigators will test the hypothesis that computer-based RI training can be a useful addition to the well-established behavior therapy to enhance its therapeutic effect.
Conditions Studied
Interventions
- BEHAVIORAL Comprehensive Behavioral Intervention for Tics (CBIT)
- BEHAVIORAL Computerized Response Inhibition Training
- BEHAVIORAL Computerized Placebo Cognitive Training
Study Locations (1)
Wisconsin
- The Psychology Clinic, University of Wisconsin-Milwaukee - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-08 |
| Est. Completion | 2014-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01440023
The ClinicalTrials.gov registry entry for NCT01440023 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 86-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (77% lower). The listed sponsor is University of Wisconsin, Milwaukee, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Tourette Syndrome appearing as the primary indexed condition, and to 3 interventions - of which Comprehensive Behavioral Intervention for Tics (CBIT) is the first listed.
NCT01440023 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT01440023 about?
NCT01440023 is a clinical study titled "Developing Cognitive Training for Tourette Syndrome". Many researchers suspect that individuals with Tourette Syndrome (TS) may have a poor cognitive ability (i.e., response inhibition; RI) that is essential to inhibit inappropriate response such as vocal or motor tics. The investigators aim to test whether a well-established behavior therapy for TS ca...
What is the current status of trial NCT01440023?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2011-08. Estimated completion is 2014-12.
What conditions does trial NCT01440023 study?
This clinical trial studies the following conditions: Tourette Syndrome, Chronic Tic Disorders.
What interventions are being tested in trial NCT01440023?
The interventions under investigation include: Comprehensive Behavioral Intervention for Tics (CBIT) (BEHAVIORAL), Computerized Response Inhibition Training (BEHAVIORAL), Computerized Placebo Cognitive Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT01440023?
This trial is sponsored by University of Wisconsin, Milwaukee, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01440023 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tourette Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Open-Trial of EPI-743 for Adults With Tourette Syndrome
COMPLETED · Phase 1
-
Sensorimotor and Psychosocial Trajectories in Adolescents With Tic Disorder
RECRUITING
-
Remote Delivery of a Mindfulness-based Intervention for Tics
RECRUITING · NA
-
Sensory Symptoms in Tourette Syndrome
RECRUITING
-
Multimodal Profiling of Response to Pediatric Comprehensive Behavioral Intervention for Tics
RECRUITING · Phase 2
-
Trajectories of Change in Tourette Syndrome
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.